Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom

OBJECTIVES: Rituximab (RTX) may be a treatment option for children and young people with JIA, although it is not licensed for this indication. The aim of this study was to describe RTX use and outcomes among children with JIA. METHODS: This analysis included all JIA patients within the UK Biologics...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearsley-Fleet, Lianne, Sampath, Sunil, McCann, Liza J, Baildam, Eileen, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343463/
https://www.ncbi.nlm.nih.gov/pubmed/30358861
http://dx.doi.org/10.1093/rheumatology/key306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343463/
https://www.ncbi.nlm.nih.gov/pubmed/30358861
http://dx.doi.org/10.1093/rheumatology/key306

Ejemplares similares